H.R. 9421 (119th)Congressional Activities

To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides

domestic policy
Cosponsors
Support
Republican
Introduced
Jun 24, 2026
Discussions
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Bill detailsDiscussionCongressional Activities

Congressional Activities

This tab collects committee work, CRS research, hearings, and amendment activity as those sources become available for the bill.

No congressional activity records are linked to this bill yet.